Who are Gemcitabine Hydrochloride Injection's main competitors?

Direct comparators (same drug class / molecular target / therapeutic area): Gemzar, Cladribine Tablets, Gemcitabine Injectable Product, Cladribine Pill, Gemcitabine monotherapy, BICTEGRAVIR SODIUM.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/gemcitabine-hydrochloride-injection.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-16 · How we verify

Gemcitabine Hydrochloride Injection — Competitive Intelligence Brief

Gemcitabine Hydrochloride Injection (Gemcitabine Hydrochloride Injection) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Nucleoside analog; antimetabolite. Area: Oncology.

phase 3 Nucleoside analog; antimetabolite Ribonucleotide reductase; DNA incorporation Oncology Small molecule Live · refreshed every 30 min

Target snapshot

Gemcitabine Hydrochloride Injection (Gemcitabine Hydrochloride Injection) — Chia Tai Tianqing Pharmaceutical Group Co., Ltd.. Gemcitabine is a nucleoside analog that inhibits ribonucleotide reductase and gets incorporated into DNA, causing chain termination and cell death.

Comparator set (6 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
Gemcitabine Hydrochloride Injection TARGET	Gemcitabine Hydrochloride Injection	Chia Tai Tianqing Pharmaceutical Group Co., Ltd.	phase 3	Nucleoside analog; antimetabolite	Ribonucleotide reductase; DNA incorporation
Gemzar	Gemcitabine Hydrochloride	Accord Hlthcare	marketed	Nucleoside metabolic inhibitor	Ribonucleotide reductase; DNA incorporation	1996-01-01
Cladribine Tablets	Cladribine Tablets	Keith Edwards, M.D.	marketed	Purine nucleoside analog	Ribonucleotide reductase; DNA incorporation
Gemcitabine Injectable Product	Gemcitabine Injectable Product	Henan Cancer Hospital	marketed	Nucleoside analog antimetabolite	Ribonucleotide reductase; DNA incorporation
Cladribine Pill	Cladribine Pill	Haukeland University Hospital	phase 3	Purine nucleoside analog	Ribonucleotide reductase; DNA incorporation
Gemcitabine monotherapy	Gemcitabine monotherapy	AstraZeneca	phase 3	Nucleoside analog; antimetabolite	Ribonucleotide reductase; DNA incorporation
BICTEGRAVIR SODIUM	BICTEGRAVIR SODIUM		marketed	Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]		2018-01-01

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

2030-06-28 — Gemzar · 12403086 · Formulation · US
2032-04-15 — Gemzar · 8679094 · Formulation · US
2033-07-01 — Gemzar · 9241948 · Formulation · US
2034-08-19 — Gemzar · 10729823 · Formulation · US
2034-08-19 — Gemzar · 12447241 · Formulation · US

Sponsor landscape (Nucleoside analog; antimetabolite class)

Assistance Publique - Hôpitaux de Paris · 1 drug in this class
Astellas Pharma Global Development, Inc. · 1 drug in this class
AstraZeneca · 1 drug in this class
Celgene · 1 drug in this class
Centre Hospitalier Universitaire Dijon · 1 drug in this class
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. · 1 drug in this class
Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd. · 1 drug in this class
Eisai Inc. · 1 drug in this class
Gruppo Italiano Malattie EMatologiche dell'Adulto · 1 drug in this class
Jiangsu Simcere Pharmaceutical Co., Ltd. · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Gemcitabine Hydrochloride Injection — Competitive Intelligence Brief. https://druglandscape.com/ci/gemcitabine-hydrochloride-injection. Accessed 2026-05-16.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab